Rivaroxaban in the prevention of thromboembolic complications in patients with atrial fibrillation

The possibilities of antithrombotic therapy in atrial fibrillation are highlighted. The alternative antithrombotic agents, including rivaroxaban presented along with the traditional drugs (acetylsalicylic acid, warfarin). Efficacy and safety of rivaroxaban is considered on the basis of the results of the ROCKET-AF study.